Quantcast
Home > Quotes > SILK

Silk Road Medical, Inc. Common Stock (SILK) Quote & Summary Data

SILK 
$48.2
*  
1.66
3.57%
Get SILK Alerts
*Delayed - data as of May 21, 2019 12:54 ET  -  Find a broker to begin trading SILK now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    SILK Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 47.81 / $ 48.40
Today's High / Low
$ 48.34 / $ 45.8005
Share Volume
64,378
50 Day Avg. Daily Volume
N/A
Previous Close
$ 46.54
52 Week High / Low
$ 48.96 / $ 30.87
Market Cap
1,478,396,425
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
64,378
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $48.20 is 56.14% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 48.34 $ 48.96
 Low: $ 45.8005 $ 30.87

Company Description (as filed with the SEC)

We are a medical device company focused on reducing the risk of stroke and its devastating impact. We believe a key to stroke prevention is minimally-invasive and technologically advanced intervention to safely and effectively treat carotid artery disease, one of the leading causes of stroke. We have pioneered a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which we seek to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines the benefits of innovative endovascular techniques with fundamental surgical principles. TCAR using our portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality profile of current treatment alternatives while providing a reduction in long-term stroke risk.  ... More ...  



Risk Grade

Where does SILK fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 46.79
Open Date:
May 21, 2019
Close Price:
$ 46.54
Close Date:
May 20, 2019


Consensus Recommendation

Analyst Info